|
Volumn 24, Issue 18, 2006, Pages 2959-2960
|
Acute coronary syndrome secondary to fluorouracil infusion
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
CISPLATIN;
FLUOROURACIL;
FOLINIC ACID;
GLYCERYL TRINITRATE;
IRINOTECAN;
OXALIPLATIN;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
ACUTE CORONARY SYNDROME;
ARTICLE;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
DIGESTIVE SYSTEM CANCER;
ECHOCARDIOGRAPHY;
HEART EJECTION FRACTION;
HEART INFARCTION;
HUMAN;
PRIORITY JOURNAL;
SIDE EFFECT;
SQUAMOUS CELL CARCINOMA;
ST SEGMENT ELEVATION;
THORAX PAIN;
TONSIL CARCINOMA;
ADULT;
BONE TUMOR;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
HEAD AND NECK TUMOR;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG TUMOR;
MALE;
METASTASIS;
PATHOLOGY;
ADULT;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
MYOCARDIAL INFARCTION;
|
EID: 33745574721
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.04.0766 Document Type: Article |
Times cited : (14)
|
References (5)
|